ABH HealthcareShare price, financial results, shareholding and management
- Market cap
- ₹44 cr
- Stock P/E
- 7.8peers 17.7
- Book value
- ₹15.2
- Price to book
- 2.53
- EV / operating profit
- -
- Market cap to sales
- 0.85
- ROCE · FY26
- 19.7%
- ROE · FY26
- 38.9%
- ROE, 3-year average
- 42.7%
- Operating margin · FY26
- 28.8%peers 16.9%
- Sales growth, 3 years
- 20.9%
- Profit growth, 3 years
- 99.5%
- Debt to equity
- 3.17peers 0.16
- Borrowings
- ₹55 cr
- Interest cover
- 2.8×
- Cash from business / op. profit
- 14%
- Debtor days
- 234
- Pledged
- 0.00%
- Promoter holding
- 69.99%
- Change in promoter holding
- -
- Shareholders
- 1,124
- High / low since listing
- ₹99 / ₹38
- Dividend yield
- 0.00%
- Face value
- ₹10
Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.
ABH Healthcare share price chart
Close on 19 Nov 2026 · -1.54% on the day · Vol 22,800
Daily prices to 19 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.
Share price returns
To the close of 19 Nov 2026
- 1 month
- -10.1%
- Since IPO
- -62.4%
- Traded a day, 20 days
- ₹0.08 cr
- Taken for delivery
- 79%
Business growth
Sales and net profit, from the reported results
| Sales | Profit | |
|---|---|---|
| FY26 on FY25 | +6% | +5% |
| 3 years, a year | +21% | +100% |
About ABH Healthcare: business, products and customers
ABH Healthcare runs the Anil Baghi Hospital, a multi speciality hospital in Ferozepur, Punjab, for patients who pay themselves, through insurance or through government health schemes. Its shares trade on NSE Emerge.
The Anil Baghi Hospital was set up in 1985 with thirty beds and was taken over by the company in March 2022 from the proprietorship of Dr. Kamal Baghi. It now has 150 beds, of which 70 are ICU beds, and offers 25 specialities; internal medicine and critical care bring in about half of revenue, with cardiology, general surgery and orthopaedics next. The pharmacy inside the hospital is outsourced, so the company books only its share of pharmacy income.
Revenue is the number of beds in use times what each occupied bed earns a day, plus out-patient fees, while staff, doctors and equipment cost much the same whether beds are full or not. Beds were added faster than patients came, so occupancy fell even as revenue per bed rose. More than half of revenue now comes from government schemes and public sector payers, which pay over time, so money owed to the hospital has climbed and cash from operations has stayed well below profit.
Read more about the business
Two partnerships in which the company holds 90% extend the hospital: Five Creeks Healthcare runs dialysis for patients under the Ayushman Bharat Sarbat Sehat Bima Yojana, and ABH Clinics runs the first off campus out-patient clinic. The offer document compares the company with the listed hospital companies Sangani Hospitals, Maitreya Medicare and Asarfi Hospital, all small hospital operators, and says it competes with government hospitals and private hospitals and clinics in its region.
From the offer document (Red Herring Prospectus, August 2026) and the company's exchange announcements.
Read the deeper study ↓In its favour
- Sales have grown fast: 21% a year over three years.
- The promoters own a large part of the company: 69.99%.
To watch
- Receivable days against the company's estimate of about 200 days for FY27 (Offer document, p.95).
- Addition of the 30 beds the board approved within the existing premises (Offer document, p.128).
- Use of the issue money set aside for unidentified acquisitions (Offer document, p.88).
- The company secretary's exit announced on 8 October 2026 and the change in auditors announced on 12 October 2026 (Exchange announcements).
- Customers take longer to pay than before: 234 days in FY26, against 24 in FY22.
From the company's documents first, then the reported figures read by fixed rules, the same for every company. Facts, not a view on the shares.
ABH Healthcare revenue and profit growth
Half-yearly results · Profit and lossSales have grown fast. Last year profit grew roughly in step with sales.
ABH Healthcare profit and loss
Full years to March, FY22 to FY26 · ₹ crore, consolidated where reported
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Sales | 3.50 | 29.19 | 39.93 | 48.55 | 51.60 |
| Expenses | 3.27 | 25.12 | 32.29 | 35.36 | 36.76 |
| Operating profit | 0.23 | 4.07 | 7.64 | 13.19 | 14.84 |
| OPM | 6.6% | 13.9% | 19.1% | 27.2% | 28.8% |
| Other income | 0 | -0.02 | -0.73 | 0.05 | -0.04 |
| Interest | 0.04 | 1.33 | 2.96 | 3.71 | 4.48 |
| Depreciation | 0.07 | 1.56 | 1.74 | 2.10 | 2.39 |
| Profit before tax | 0.12 | 1.16 | 2.21 | 7.43 | 7.93 |
| Tax rate | 33.3% | 38.8% | 24.9% | 28.0% | 28.9% |
| Net profit | 0.09 | 0.71 | 1.66 | 5.35 | 5.64 |
| EPS ₹ | 9 | 3.55 | 8.30 | 26.70 | 7.06 |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
ABH Healthcare profitability
Margins and returns on capitalLast year the company kept about as much from each rupee of sales as the year before. It earns a moderate return on the money it uses.
Operating margin, every year
Per cent of sales kept before interest, depreciation and tax
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Operating margin | 6.6% | 13.9% | 19.1% | 27.2% | 28.8% |
| Tax rate | 33.3% | 38.8% | 24.9% | 28.0% | 28.9% |
| ROCE | · | 10.7% | 15.2% | 23.3% | 19.7% |
| ROE | · | 29.0% | 30.0% | 59.3% | 38.9% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
ABH Healthcare debt and cash flow
Balance sheet · Cash flow · Working capitalThe company's own money, its net worth, has grown fast. Its loans are now larger than its own money. Last year the business brought in less cash than it showed as profit, so part of the profit is still to be collected. It spent more on assets and investments than the business brought in, and raised the rest from loans or shares. Customers take longer to pay than they did in FY24, which ties up more of the company's money in unpaid bills.
Bars below the line are cash going out.
ABH Healthcare balance sheet
At each 31 March · ₹ crore
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Equity capital | 0.10 | 2 | 2 | 2 | 8 |
| Reserves | 0.09 | 2.70 | 4.35 | 9.69 | 9.34 |
| Net worth | 0.19 | 4.70 | 6.35 | 11.69 | 17.34 |
| Borrowings | 20.62 | 20.97 | 35.79 | 41.88 | 55.03 |
| Other liabilities | 5.46 | 7.29 | 9.20 | 10.33 | 12.90 |
| Total liabilities | 26.27 | 32.96 | 51.34 | 63.90 | 85.27 |
| Fixed assets | 23.48 | 22.73 | 33.81 | 36.68 | 41.92 |
| Capital work in progress | 0 | 0.63 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0.12 | 0.29 | 1.74 |
| Other assets | 2.79 | 9.60 | 17.41 | 26.93 | 41.61 |
ABH Healthcare cash flow
₹ crore
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Cash from operations | 3.06 | -1.55 | 0.89 | 3.54 | 2.11 |
| Cash from investing | -23.55 | -1.45 | -13.06 | -4.53 | -9.14 |
| Cash from financing | 20.70 | 2.94 | 12.04 | 1.58 | 9.45 |
| Net cash flow | 0.21 | -0.06 | -0.13 | 0.59 | 2.42 |
Working capital
Days
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Debtor days | 24 | 74 | 110 | 148 | 234 |
| Inventory days | · | · | · | 159 | 117 |
| Days payable | · | · | · | 242 | 239 |
| Cash conversion cycle | 24 | 74 | 110 | 66 | 113 |
| Working capital days | -985 | -59 | -17 | 36 | 172 |
ABH Healthcare peers and competitors
Listed SME companies in the same industryBy sales, ABH Healthcare is number 11 of the 23 listed SME companies in healthcare services.
Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.
| Company | Market cap ₹ cr | P/E | Sales ₹ cr | Profit ₹ cr | Op. margin | Debt/equity |
|---|---|---|---|---|---|---|
| Nephro Care India | 141 | 41.9 | 88.7 | 3.4 | 9.4% | 0.00 |
| Modern Diagnostic & Research Centre | 95 | 18.1 | 83.1 | 5.3 | 15.4% | 0.63 |
| Pramodini Medicare | 254 | 15.0 | 62 | 17 | 50.0% | 0.34 |
| Adeshwar Meditex | - | - | 56.1 | 1.3 | 4.9% | 0.16 |
| ABH Healthcare | 44 | 7.8 | 51.6 | 5.6 | 28.8% | 3.17 |
| Shanmuga Hospital | 57 | 13.4 | 45 | 4.2 | 18.4% | 0.16 |
| Maitreya Medicare | 80 | - | 44.9 | -2.5 | -0.7% | 0.80 |
| Invicta Diagnostic | 84 | 17.3 | 32.4 | 4.9 | 30.2% | 0.07 |
| Nidan Laboratories and Healthcare | 19 | 12.4 | 25.5 | 1.5 | 19.0% | 0.16 |
| Aatmaj Healthcare | 50 | 69.7 | 24.3 | 0.7 | 9.7% | 0.41 |
| Aashka Hospitals | 243 | 72.8 | 23 | 3.3 | 22.8% | 0.08 |
| Median of the 10 others | 84 | 17.7 | 44.9 | 3.4 | 16.9% | 0.16 |
ABH Healthcare shareholding pattern
Promoters, FIIs, DIIs, HNIs and small holdersThe promoters own more than half the company. Big foreign and Indian funds own very little.
ABH Healthcare shareholding pattern
Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.
| Aug 26 | |
|---|---|
| Promoters | 69.99% |
| Foreign investors (FIIs) | 3.00% |
| HNIs (over ₹2 lakh each) | 0.42% |
| Small holders (up to ₹2 lakh) | 23.71% |
| Companies and others | 2.88% |
| Number of shareholders | 1,124 |
The named holders are at 31 Aug 2026, each under the group the pattern files them in.
ABH Healthcare study: the business from its own documents
Read from 1 of the company's own documentsABH Healthcare so far
From the company's own record
- 1 Sept 2026Listed on NSE Emerge at ₹102
- 17 Sept 2026An order announced
- 31 Aug 2026Promoters at 69.99%
- 1 Sept 2026Highest close since listing, ₹94.05
ABH Healthcare key facts from the filings
Each figure with the document it comes from
- Beds
- 150
- Total bed capacity in FY26, with 125 beds in operation and 70 of them ICU beds; it was 100 in FY24.Offer document, p.128
- Bed occupancy
- 47%
- Share of operational bed days used in FY26, down from 49% in FY25 and 63% in FY24 as beds were added.Offer document, p.128
- Revenue per occupied bed
- ₹19,992
- Average a day in FY26, up from ₹18,245 in FY25.Offer document, p.128
- Government schemes and PSUs
- 52.40%
- Share of FY26 revenue paid through government schemes and public sector payers, up from 43.44% in FY24; self pay fell to 31.85%.Offer document, p.132
- Days to get paid
- 239 days
- Trade receivables held in FY26, up from 149 days in FY25; the company estimates about 200 days for FY27.Offer document, p.95
Show 5 more facts
- Top two payers
- 42.51%
- Share of FY26 revenue from the two largest payers; the top ten gave 59.15%.Offer document, p.233 to 234
- Medical team
- 37 doctors
- At June 2026, 27 full time and 10 part time, with 101 nurses among 309 staff.Offer document, p.142
- Debt to equity
- 2.99
- At March 2026, down from 5.69 in FY24; loans carry personal guarantees of the promoters.Offer document, p.128 and p.234 to 235
- IPO for loans
- ₹17.0 cr
- Largest planned use of the issue money, with ₹5.0 cr for working capital and the rest for unidentified acquisitions and general purposes.Offer document, p.88
- More beds approved
- 30
- Beds the board approved in April 2025 to add within the existing premises.Offer document, p.128
What the company said, and what happened
The company's own statements, attributed, set against what it later reported; not newboard's estimates
The company says the board has approved adding 30 beds within the existing premises, and that it plans urgent care centres in nearby towns, more off campus clinics and growth through asset light arrangements or acquisitions; no acquisition had been agreed at the offer document. It estimates trade receivables of about 200 days in FY27, against 239 days in FY26.
Is it a good business? Six questions
Each answer is about that one question, read from the documents; tap one for the evidence. Not a view on the shares.
ABH Healthcare earns from one established hospital in Ferozepur, where more patients in its beds and more complex care lift income over largely fixed costs.
Its weak spots are a single location, many empty beds after expansion, and slow payment from government schemes.
AverageCan it set its own prices?Revenue per occupied bed has risen, but more than half of revenue comes through government schemes and public sector payers, and the company warns competition could push prices down.
AverageHow strong is it against rivals?It is a long running hospital with accreditation and many specialities, but it competes with government and private hospitals in the same region.
WatchWho are its customers?Patients come from one town and its surroundings, and a large part of the bill is paid by a few government and insurance payers.
WatchDoes it need a lot of money?Beds and equipment were built on borrowed money, and slow collections tie up more cash as revenue grows.
AverageCan it keep finding new work?It is tied into insurers and all major government schemes in the region, but occupancy has fallen for two years as beds were added.
StrongDo good and bad years swing a lot?Hospital demand is steady through the year, and patient numbers have held up while capacity grew.
Who runs ABH Healthcare?
Promoters, directors and officers; tap a name for the background
DKDr. Kamal BaghiPromoter, Chairman and Whole-time Director · holds 21.00%
Holds a master's degree of medicine from Guru Nanak Dev University and has about four decades in healthcare. Founded Anil Baghi Hospital in 1985 and was a founding member of Anil Baghi School of Nursing, Genesis Institute of Dental Sciences and Research and Anil Baghi College of Nursing. Responsible for the overall management of the company.
Offer document, p.160 to 161DSDr. Saurabh BaghiPromoter and Managing Director · holds 47.95%
A non-invasive cardiologist with an MBBS from Baba Farid University of Health Sciences, an MD in Internal Medicine from The Brooklyn Hospital Center and a cardiology and heart failure fellowship at Mt. Sinai Hospital, New York; worked as a consultant cardiologist at Parkview Medical Center, Colorado, from 2014 and joined the hospital on return to India in 2020. Managing Director to May 2028. The offer document states Dr. Kamal Baghi is the father of Dr. Saurabh Baghi.
Offer document, p.129, p.160 to 162 and p.163DVDr. Vaishali SainiPromoter and Non-Executive Director · holds 1.05%
An ABPN certified neurologist with an MBBS from Baba Farid University of Health Sciences, trained in neurology at New York Presbyterian Hospital, Cornell Campus; later Director for stroke at Parkview Medical Center, Colorado. Oversees hiring and training of nursing staff. The offer document states Dr. Vaishali Saini is the spouse of Dr. Saurabh Baghi.
Offer document, p.129 to 130 and p.162DSDr. Satnam Singh NijjarIndependent Director
Holds a master's degree of surgery from Guru Nanak Dev University and has over 20 years in healthcare; Managing Director of Nijjar Hospitals in Batala. On the board since January 2025.
Offer document, p.161 to 162BSBalwinder SinghIndependent Director
Holds a BA from Jawaharlal Nehru University and a master's in defence and strategic studies from Madras University; retired from the Indian Army as Major General after over 30 years. On the board since January 2025.
Offer document, p.161 to 162RARajeev AgarwalChief Financial Officer
A Chartered Accountant with more than three decades in accounts and finance, earlier with Eicher Tractors, Jindal Iron and Steel, Reliance Communications and as CFO of Ivy Hospital. Appointed in February 2025.
Offer document, p.172ABH Healthcare latest news and announcements
Announcements · Documents · Corporate actionsWhat changed recently
Each half-year is set against the same half a year earlier
- 17 Sept 2026: an order announced.
ABH Healthcare announcements
10 on record, latest first; each opens the filing on the exchange
- Change in AuditorsOf the companyPDF ↗
- Change in Company Secretary/Compliance OfficerChange in Company Secretary/Compliance OfficerPDF ↗
- Outcome of Board MeetingHeld on October 12, 2026PDF ↗
- Resignation of Director/KMP/SMPResignation of Director/KMP/SMPPDF ↗
- CessationOf RAHUL SHARMA as Company Secretary & Compliance Officer of the company w.e.f. October 07, 2026PDF ↗
- Trading WindowClosure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015PDF ↗
- Updates'Price movement'PDF ↗
- Price movementSignificant movement in price has been observed in ABH Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information abouPDF ↗
- Arrangements for strategic, technical, manufacturing, or marketing tie upArrangements for strategic, technical, manufacturing, or marketing tie upPDF ↗
- Utilisation of FundsUtilisation of FundsPDF ↗
ABH Healthcare annual reports, earnings calls and documents
Every document links to its source; “read” marks those this page is built from
- Offer document ↗read
ABH Healthcare share split, bonus and dividends
From the corporate actions the company announces on the exchange
No share split, bonus issue or dividend is on record since listing.
Checks we ran on ABH Healthcare's data · 8
Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.
- ✓Balance sheet totals add up for FY25 and FY26.
- ✓Market cap uses the share count in the latest shareholding pattern (1,14,29,600 shares).
- !The FY26 results imply 80,00,000 shares at face value ₹10, which disagrees with the shareholding pattern; the pattern is used.
- ✓Promoter pledge figures are within possible limits in every shareholding pattern shown.
- ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
- !Earnings per share changes basis between FY22 (₹9.00) and FY23 (₹3.55) because the share count behind it changes; EPS is shown as reported, and growth is worked out on profit.
- ✓Revenue and profit are reported for every year shown, FY22 to FY26.
- iPrices run to the close on 14 Oct 2026, from the exchange's daily figures.
Questions people ask about ABH Healthcare
What does ABH Healthcare do?
ABH Healthcare runs the Anil Baghi Hospital, a multi speciality hospital in Ferozepur, Punjab, for patients who pay themselves, through insurance or through government health schemes. Its shares trade on NSE Emerge.
What is the share price of ABH Healthcare?
₹38.4 at the close on 19 Nov 2026, from the exchange's daily figures.
What is the market cap of ABH Healthcare?
₹44 cr at the close on 19 Nov 2026, on 1,14,29,600 shares.
What is the P/E of ABH Healthcare?
7.8 times FY26 profit at the close on 19 Nov 2026 (our arithmetic).
What are ABH Healthcare's revenue and profit?
Revenue ₹52 cr and profit after tax ₹6 cr in FY26.
Who are the promoters of ABH Healthcare?
Dr. Kamal Baghi, Dr. Saurabh Baghi, Dr. Vaishali Saini; promoters held 69.99% at 31 Aug 2026.
What was the IPO price of ABH Healthcare?
₹102 a share; it listed on 1 Sept 2026.
More SME companies like ABH Healthcare
Other listed SME companies in healthcare services, the closest in size first, each read from its own documents.
- Aatmaj HealthcareAATMAJ · NSE Emerge · Healthcare Services · listed 2023Market cap ₹58 cr
- Shanmuga HospitalSHANMUGA · BSE SME · Healthcare ServicesMarket cap ₹63 cr
- KK Shah HospitalsKKSHL · BSE SME · Healthcare ServicesMarket cap ₹29 cr
- Sangani HospitalsSANGANI · NSE Emerge · Healthcare Services · listed 2023Market cap ₹76 cr
- Maitreya MedicareMAITREYA · NSE Emerge · Healthcare Services · listed 2023Market cap ₹78 cr
- Modern Diagnostic & Research CentreMDRC · BSE SME · Healthcare ServicesMarket cap ₹79 cr
Every listed SME company in Healthcare Services → · SME companies listed in 2026 →
Built from 1 offer document, 10 exchange announcements, 1 shareholding patterns and 5 years of reported results. Every figure carries its source; where the documents are silent, the page says so.